
Chembio Diagnostics CEMI
Quartalsbericht 2022-Q3
hinzugefügt 23.05.2026
Chembio Diagnostics DSO 2011-2026 | CEMI
DSO Jährlich Chembio Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66.3 | 56.6 | 39.6 | 58.4 | 49.9 | 41.6 | 59.3 | 81 | 85.4 | 58.1 | 55.7 | 65.4 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 85.4 | 39.6 | 59.8 |
DSO Vierteljährlich Chembio Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 38.7 | 70.4 | 51.7 | - | 36.9 | 38.1 | 30.3 | - | 27.2 | 66.8 | 56.8 | - | 61.5 | 73.5 | 83 | - | 71.4 | 56 | 34.9 | 59.8 | 62.8 | 115 | 65.4 | 81.4 | 107 | 132 | 50.6 | 123 | 122 | 116 | 122 | - | 85.7 | 54 | 62.5 | - | 44.6 | 77.6 | 69 | - | 43.6 | 43.7 | 45.4 | - | 12.7 K | 20.8 K | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 20.8 K | 27.2 | 946 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
94.7 | $ 4.5 | -10.89 % | $ 5.99 M | ||
|
Fulgent Genetics
FLGT
|
87 | $ 18.5 | 1.04 % | $ 569 M | ||
|
Castle Biosciences
CSTL
|
50.2 | $ 21.08 | 4.77 % | $ 611 M | ||
|
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
72.7 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
63.4 | $ 151.82 | -0.28 % | $ 11.9 B | ||
|
Illumina
ILMN
|
66.8 | $ 160.03 | 1.26 % | $ 24.8 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
46.1 | $ 130.12 | 4.19 % | $ 16.3 B | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 22.75 | 3.64 % | $ 1.21 B | ||
|
Interpace Biosciences
IDXG
|
66.9 | $ 1.74 | 3.57 % | $ 7.7 M | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
NeoGenomics
NEO
|
77.7 | $ 11.44 | 4.47 % | $ 1.47 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 19.75 | 2.17 % | $ 442 M | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
80.5 | $ 99.98 | -0.03 % | $ 6.75 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 189.85 | 1.83 % | $ 9.41 B | ||
|
Pacific Biosciences of California
PACB
|
71.8 | $ 1.37 | -0.72 % | $ 411 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 466.79 | 1.94 % | $ 13.5 B | ||
|
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 162.79 | 2.1 % | $ 24 B | ||
|
Myriad Genetics
MYGN
|
52.3 | $ 4.54 | 3.42 % | $ 420 M | ||
|
Natera
NTRA
|
48.3 | $ 222.82 | 4.38 % | $ 30.5 B | ||
|
Personalis
PSNL
|
63.8 | $ 9.75 | -2.89 % | $ 870 M | ||
|
Senseonics Holdings
SENS
|
1.04 | $ 7.43 | 4.21 % | $ 310 M | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
27 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
57.7 | $ 2.05 | -0.92 % | $ 4.71 M | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 271.24 | 3.52 % | $ 22.6 B | ||
|
Twist Bioscience Corporation
TWST
|
44.5 | $ 70.06 | 0.03 % | $ 4.19 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 494.07 | 5.23 % | $ 186 B | ||
|
Trinity Biotech plc
TRIB
|
87.2 | $ 0.66 | -2.32 % | $ 237 M | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
66.6 | $ 9.29 | 2.43 % | $ 2.01 B | ||
|
Waters Corporation
WAT
|
306 | $ 371.15 | 2.15 % | $ 22.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 204.53 | 3.71 % | $ 22.7 B |